BRIEF published on 04/10/2024 at 15:05, 1 year 7 months ago Canadian Nursery Big League Genetics Begins Exporting Cannabis Genetics to Germany's DEMECAN 3Win Corp Big League Genetics DEMECAN European Cannabis Market Cannabis Legislation
BRIEF published on 04/10/2024 at 15:05, 1 year 7 months ago La Big League Genetics de la pépinière canadienne commence à exporter des génétiques de cannabis vers la société allemande DEMECAN DEMECAN Génétique De La Grande Ligue 3WIN Corp. Marché Européen Du Cannabis Législation Sur Le Cannabis
PRESS RELEASE published on 04/10/2024 at 15:00, 1 year 7 months ago Canadian Nursery Big League Genetics Exporting New Strains to German Cannabis Producer DEMECAN Big League Genetics partners with DEMECAN to introduce international genetics to European markets. The collaboration signifies a milestone amid Germany's recent cannabis legalization Cannabis Legalization Big League Genetics DEMECAN International Genetics European Markets
Published on 12/05/2025 at 02:35, 4 hours 54 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 29 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 24 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 29 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 29 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 59 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 38 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 4 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 14 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 14 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 29 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 29 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 44 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 44 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
